Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform
The race towards the development of user-friendly, portable, fast-detection, and low-cost devices for healthcare systems has become the focus of effective screening efforts since the pandemic attack in December 2019, which is known as the coronavirus disease 2019 (COVID-19) pandemic. Currently exist...
Main Authors: | Reena Sri Selvarajan, Subash C. B. Gopinath, Noraziah Mohamad Zin, Azrul Azlan Hamzah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/21/11/3829 |
Similar Items
-
The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection
by: Douglas L. Archer, et al.
Published: (2020-06-01) -
Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
by: Si Chen, et al.
Published: (2019-06-01) -
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
by: Mankgopo Magdeline Kgatle, et al.
Published: (2021-10-01) -
Interleukin-12 as a biomarker of the beneficial effects of food restriction in mice receiving high fat diet or high carbohydrate diet
by: C.B. de Almeida-Souza, et al.
Published: (2018-11-01) -
Protein Levels of Pro-Inflammatory Cytokines and Chemokines as Biomarkers of Mycobacterium bovis Infection and BCG Vaccination in Cattle
by: Connelley, T.K, et al.
Published: (2022)